CTRI/2023/01/048840尚未招募2/3 期
A single arm clinical study to evaluate the efficacy of Dadimadi Churna in the management of Peenasa (Chronic Rhinitis) in children
Dr. Saurabh Mhaske1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年3月15日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- Reduction in the symptoms of Peenasa
研究概览
简要总结
This is a single arm clinical study in which medicine Dadimadi Churna will be provided to 36 patients showing classical sign and symptoms of Peenasa for releving symptoms . The study will be between the age group of 3 years to 12 years . Dose will be calculated by youngs formula ,follow up on 3rd day and 7th day
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 3.00 Year(s) 至 12.00 Year(s)（—）
- 性别
- All
入选标准
- •The patients having at least 2 – 3 symptoms of Peenasa are as follows- Nasastrava,Frequency of Kshavathu ,Nasavarodha, Nasakandu and Shirashoola.The patients of age from 3 year to 12 years.
- •The patients who separents are ready to participate in the clinical trial by giving informed written consent.
排除标准
- •Patients and his/her parents/guardian not willing for trial.Patients having life threatening illness and who is bedridden.Patient who need surgical and other intervention.Patients presenting with symptoms of Dushta Peenasa/ Pratishyaya and Raktaga.Patients suffering with other Nasal diseases like Nasal Polyps, Nasal Septum Patients associated with Nasal Malignancy.
结局指标
主要结局
Reduction in the symptoms of Peenasa
时间窗: 7 day study , 0th,3rd ,7th day
次要结局
- To observe the adverse effect of Dadimadi Churna(7 day study , 0th,3rd ,7th day)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAXBrain DiseasesVertebral Artery ThrombosisVertebral Artery StenosisNCT06186024MicroPort NeuroTech Co., Ltd.36
招募中
2/3 期
A study of Thermal cautery (Agnikarma) in treatment of Achilles Tendinitis.CTRI/2021/11/037951DR PRATHAMESH PRADEEP KASHIKAR31
Enrolling By Invitation
2 期
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With TrilaciclibNon-small Cell Lung CancerNCT06370416Henan Cancer Hospital41
招募中
2/3 期
To Study the Effect of Shreerasadi Churna in Decreasing Diarrhea in Childrean Age Group 1 to 12 Year.CTRI/2025/05/086251Dr Omkar Sampat Madake32
尚未招募
2/3 期
A STUDY OF INDRAVARUNI MALHAR (OINTMENT) IN THE TREATMENT OF BREAST ENGORGEMENT (STANASHOTHA) IN SUTIKA (POST- NATAL)CTRI/2021/11/037954DR SONALI SAMPAT GHORPADE40